| Tumorigenic behaviour of c-Ha-ras oncogene transfected CaCo 2 cells is associated with increased proteolytic potency. | None |
| Novel anti-carcinogenic activity of an organosulfide from garlic: inhibition of H-RAS oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21H-ras processing. | None |
| Dome formation induced by v-H-ras oncogene in a human choriocarcinoma cell line. | None |
| Transfection of C3H10T1/2 cells with the Harvey-ras oncogene reduces cytosolic phospholipase A2 function. | None |
| [Characteristics of DNA-binding activity of SRF factor in cells, transformed by the Ha-ras oncogene]. | None |
| Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats. | None |
| A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61. | None |
| Ha-ras oncogene transformation abolishes retinoic acid-induced reduction of intracellular fibronectin. | None |
| Effects of bradykinin on NIH 3T3 fibroblasts pretreated with lithium. Mimicking events of Ha-ras oncogene expression. | None |
| Antisense properties of end-modified oligonucleotides targeted to Ha-ras oncogene. | None |
| H-ras oncogene point mutations in arthritic synovium. | None |
| Osteopontin overexpression in vascular smooth muscle cells transfected with the c-Ha-rasEJ oncogene. | None |
| The association of the H-ras oncogene and steroid hormone receptors in gynecological cancer. | None |
| Micro-injection of recombinant lysyl oxidase blocks oncogenic p21-Ha-Ras and progesterone effects on Xenopus laevis oocyte maturation. | None |
| Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. | None |
| Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin. | None |
| Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. | None |
| p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation. | None |
| [E1A-induced apoptosis in rat embryonal fibroblasts is not suppressed by introducing the c-Ha-ras oncogene]. | None |